You can email us at, or call us on 01202 539791.Email: Phone: 01202 539791.


Axitinib, Free Base

Axitinib (AG013736, trade name Inlyta is a small molecule tyrosine kinase inhibitor developed by Pfizer. It has been shown to significantly inhibit growth of breast cancer in animal models and has shown partial responses in clinical trials with  renal cell carcinoma(RCC) and several other tumour types. It was approved by the U.S. Food and Drug Administration after showing a modest increase in progression-free survival, though there have been reports of fatal adverse effects.

Product Details

Category Cancer Research and Antivirals
Price POA
CAS Number 319460-85-0
Formula C22H18N4OS
Molecular Weight 386.47
Purity 99%
Appearance white to off white crystalline solid
Availability In Stock
Storage Conditions -18°C

Product Enquiry

Send us your enquiry for Axitinib, Free Base. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.

We value your input so if you have suggestions regarding new applications for Axitinib, Free Base email us and we will include your contribution on the website.

Enquire about product

Back to Top